Home>Topics>Stocks>Ariad Pharmaceuticals

Ariad Pharmaceuticals

  1. All
  2. Headlines
  1. Ariad adopts rights plan to protect tax assets

    Headlines

    Fri, 1 Nov 2013

    Nov 1 (Reuters) - Ariad Pharmaceuticals Inc adopted a shareholder rights plan to protect its tax credits, a day after sales of its flagship drug Iclusig were suspended due to safety concerns...

  2. Ariad shares fall as FDA panel fails to back cancer drug

    Headlines

    Wed, 21 Mar 2012

    (Reuters) - Ariad Pharmaceuticals ' shares fell 3 percent on Wednesday morning after a U.S. Food and Drug Administration panel did not recommend the company's experimental cancer candidate.

Content Partners